Welcome to the Impact of Neutropenia in Chemotherapy European (INC-EU) study group

The INC-EU study group aims to raise awareness of chemotherapy-induced neutropenia (CIN) and febrile neutropenia (FN) and reduce its occurrence.


 The INC-EU study group has been approached by Science Omega to write a position piece on neutropenia, the group's research and the National Institute for Health and Clinical Excellence (NICE) guidance on neutropenic sepsis prevention and management. The resulting short article 'Neutropenia in cancer treatment - familiar but not resolved' has been published in the Science Omega Review UK Issue 1 and can be accessed here.

Last update: 2014-03-04

The content of this website is intended for healthcare professionals.
All content is approved by the INC-EU study group members.

The INC-EU and this website are supported by an educational grant from

Amgen (Europe) GmbH.